WHO ICTRP trial
Phase 1, Open, Dose-escalation Study to Assess the Efficacy and Safety of…
ChiCTR-TNRC-11001251 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TNRC-11001251 |
|---|---|
| Public title | Phase 1, Open, Dose-escalation Study to Assess the Efficacy and Safety of Fospropofol Disodium Injection in Healthy Volunteers |
| Scientific title | Phase 1, Open, Dose-escalation Study to Assess the Efficacy and Safety of Fospropofol Disodium Injection in Healthy Volunteers |
| Primary sponsor | Yichang HumanWell Pharmaceutical Co.,Ltd |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | I (Phase I study) |
| Countries | China |
| Conditions | Induction of anesthesia |
| Interventions | Group A:Fospropofol Disodium as a bolus injection |
| Registration date | Jan 3, 2011 |
| Target size | Group A:80 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: